Since the KIAA1549-BRAF fusions are highly prevalent in pediatric PA, this feature can be used as a supportive diagnostic marker in cases where neuropathological distinction from other gliomas is difficult [19, 20]. The gene discussed is BRAF; the disease is central nervous system cancer.